

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.69278531 |
| 2 | base-excision repair, AP site formation (GO:0006285) | 4.99462157 |
| 3 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.79887307 |
| 4 | proteasome assembly (GO:0043248) | 4.73405306 |
| 5 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.73390321 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 4.65763410 |
| 7 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.65335605 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.61792636 |
| 9 | DNA strand elongation (GO:0022616) | 4.58218347 |
| 10 | regulation of mitochondrial translation (GO:0070129) | 4.56876474 |
| 11 | guanosine-containing compound biosynthetic process (GO:1901070) | 4.37561198 |
| 12 | UTP biosynthetic process (GO:0006228) | 4.27144330 |
| 13 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 4.26664080 |
| 14 | DNA replication initiation (GO:0006270) | 4.26500183 |
| 15 | nucleobase biosynthetic process (GO:0046112) | 4.25734783 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 4.21154520 |
| 17 | * iron-sulfur cluster assembly (GO:0016226) | 4.18913002 |
| 18 | * metallo-sulfur cluster assembly (GO:0031163) | 4.18913002 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.17727943 |
| 20 | GTP biosynthetic process (GO:0006183) | 4.17527541 |
| 21 | purine nucleobase biosynthetic process (GO:0009113) | 4.17427422 |
| 22 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.15259858 |
| 23 | telomere maintenance via recombination (GO:0000722) | 4.14028171 |
| 24 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 4.13876508 |
| 25 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.04898140 |
| 26 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.01466791 |
| 27 | DNA replication checkpoint (GO:0000076) | 4.00058149 |
| 28 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.98959433 |
| 29 | chaperone-mediated protein transport (GO:0072321) | 3.94655748 |
| 30 | UTP metabolic process (GO:0046051) | 3.91257842 |
| 31 | CTP biosynthetic process (GO:0006241) | 3.90513176 |
| 32 | CTP metabolic process (GO:0046036) | 3.90513176 |
| 33 | deoxyribonucleotide catabolic process (GO:0009264) | 3.89803227 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.83975548 |
| 35 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.83899831 |
| 36 | ribosomal small subunit biogenesis (GO:0042274) | 3.82123450 |
| 37 | nuclear envelope reassembly (GO:0031468) | 3.81519268 |
| 38 | mitotic nuclear envelope reassembly (GO:0007084) | 3.81519268 |
| 39 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.80833017 |
| 40 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.79805109 |
| 41 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.79532108 |
| 42 | protein targeting to mitochondrion (GO:0006626) | 3.79503778 |
| 43 | termination of RNA polymerase III transcription (GO:0006386) | 3.79010304 |
| 44 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.79010304 |
| 45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.78974267 |
| 46 | ribosome biogenesis (GO:0042254) | 3.78879639 |
| 47 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.78451198 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.74225999 |
| 49 | negative regulation of ligase activity (GO:0051352) | 3.74225999 |
| 50 | viral transcription (GO:0019083) | 3.74156950 |
| 51 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.74000173 |
| 52 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.72754062 |
| 53 | pseudouridine synthesis (GO:0001522) | 3.71479168 |
| 54 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.69359059 |
| 55 | mitotic recombination (GO:0006312) | 3.67972368 |
| 56 | translational termination (GO:0006415) | 3.66688212 |
| 57 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.66540821 |
| 58 | histone arginine methylation (GO:0034969) | 3.65890448 |
| 59 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.65778284 |
| 60 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.63050370 |
| 61 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.62849739 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 3.62849739 |
| 63 | protein complex biogenesis (GO:0070271) | 3.61747335 |
| 64 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.60726783 |
| 65 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.60726783 |
| 66 | deoxyribose phosphate catabolic process (GO:0046386) | 3.60566320 |
| 67 | peptidyl-histidine modification (GO:0018202) | 3.60259022 |
| 68 | telomere maintenance via telomere lengthening (GO:0010833) | 3.59861293 |
| 69 | establishment of protein localization to mitochondrion (GO:0072655) | 3.59676424 |
| 70 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.59589603 |
| 71 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.59589603 |
| 72 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.59589603 |
| 73 | rRNA modification (GO:0000154) | 3.58998234 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.54473691 |
| 75 | rRNA processing (GO:0006364) | 3.53867048 |
| 76 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.53633164 |
| 77 | NADH dehydrogenase complex assembly (GO:0010257) | 3.53633164 |
| 78 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.53633164 |
| 79 | ribosomal large subunit biogenesis (GO:0042273) | 3.50449480 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.50447860 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.50447860 |
| 82 | protein insertion into membrane (GO:0051205) | 3.49151776 |
| 83 | ribosome assembly (GO:0042255) | 3.46562078 |
| 84 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.46177930 |
| 85 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.45708500 |
| 86 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.43260647 |
| 87 | 7-methylguanosine mRNA capping (GO:0006370) | 3.42961122 |
| 88 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.42842597 |
| 89 | translational elongation (GO:0006414) | 3.42770583 |
| 90 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.40188104 |
| 91 | rRNA metabolic process (GO:0016072) | 3.39917468 |
| 92 | translational initiation (GO:0006413) | 3.39896496 |
| 93 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.36487829 |
| 94 | 7-methylguanosine RNA capping (GO:0009452) | 3.36254872 |
| 95 | RNA capping (GO:0036260) | 3.36254872 |
| 96 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.35549228 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.35374702 |
| 98 | spliceosomal snRNP assembly (GO:0000387) | 3.35096214 |
| 99 | CENP-A containing nucleosome assembly (GO:0034080) | 3.34863068 |
| 100 | cotranslational protein targeting to membrane (GO:0006613) | 3.34624815 |
| 101 | peptidyl-arginine N-methylation (GO:0035246) | 3.33263506 |
| 102 | peptidyl-arginine methylation (GO:0018216) | 3.33263506 |
| 103 | L-methionine salvage (GO:0071267) | 3.33262636 |
| 104 | L-methionine biosynthetic process (GO:0071265) | 3.33262636 |
| 105 | amino acid salvage (GO:0043102) | 3.33262636 |
| 106 | protein targeting to ER (GO:0045047) | 3.32823361 |
| 107 | negative regulation of B cell apoptotic process (GO:0002903) | 3.31481461 |
| 108 | mitotic metaphase plate congression (GO:0007080) | 3.30256293 |
| 109 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.29819775 |
| 110 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.29819775 |
| 111 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.29055186 |
| 112 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.28425666 |
| 113 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.28155167 |
| 114 | cell cycle G1/S phase transition (GO:0044843) | 3.28155167 |
| 115 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.28103428 |
| 116 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.27011785 |
| 117 | protein localization to mitochondrion (GO:0070585) | 3.26408574 |
| 118 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24609371 |
| 119 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24609371 |
| 120 | GMP metabolic process (GO:0046037) | 3.24350797 |
| 121 | translation (GO:0006412) | 3.23405394 |
| 122 | chromatin remodeling at centromere (GO:0031055) | 3.23369629 |
| 123 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.22584254 |
| 124 | protein localization to endoplasmic reticulum (GO:0070972) | 3.22517314 |
| 125 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.22388998 |
| 126 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.20151013 |
| 127 | positive regulation of ligase activity (GO:0051351) | 3.19895569 |
| 128 | negative regulation of cell size (GO:0045792) | 3.18581532 |
| 129 | ncRNA 3-end processing (GO:0043628) | 3.17203752 |
| 130 | proline biosynthetic process (GO:0006561) | 3.17196111 |
| 131 | oxidative phosphorylation (GO:0006119) | 3.17063870 |
| 132 | respiratory electron transport chain (GO:0022904) | 3.17015955 |
| 133 | folic acid metabolic process (GO:0046655) | 3.14085877 |
| 134 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.14064059 |
| 135 | electron transport chain (GO:0022900) | 3.13703413 |
| 136 | rRNA transcription (GO:0009303) | 3.12239750 |
| 137 | IMP biosynthetic process (GO:0006188) | 3.11179249 |
| 138 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.11160334 |
| 139 | DNA unwinding involved in DNA replication (GO:0006268) | 3.10540430 |
| 140 | base-excision repair (GO:0006284) | 3.08807678 |
| 141 | tRNA modification (GO:0006400) | 3.08628652 |
| 142 | cellular component biogenesis (GO:0044085) | 3.07878977 |
| 143 | viral mRNA export from host cell nucleus (GO:0046784) | 3.06855320 |
| 144 | maturation of 5.8S rRNA (GO:0000460) | 3.06367520 |
| 145 | deoxyribose phosphate metabolic process (GO:0019692) | 3.04619803 |
| 146 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.04424687 |
| 147 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.04286745 |
| 148 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.04286745 |
| 149 | pentose metabolic process (GO:0019321) | 3.01420010 |
| 150 | protein deneddylation (GO:0000338) | 3.01015824 |
| 151 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.00734379 |
| 152 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.99939895 |
| 153 | tRNA methylation (GO:0030488) | 2.99392216 |
| 154 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.99013836 |
| 155 | cullin deneddylation (GO:0010388) | 2.98177520 |
| 156 | respiratory chain complex IV assembly (GO:0008535) | 2.97522741 |
| 157 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.97408899 |
| 158 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.96789681 |
| 159 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.96264364 |
| 160 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.95224461 |
| 161 | cytochrome complex assembly (GO:0017004) | 2.95178635 |
| 162 | regulation of ligase activity (GO:0051340) | 2.93417050 |
| 163 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.92858301 |
| 164 | DNA replication-independent nucleosome organization (GO:0034724) | 2.92858301 |
| 165 | viral life cycle (GO:0019058) | 2.92267549 |
| 166 | cellular protein complex disassembly (GO:0043624) | 2.92006240 |
| 167 | transcription from RNA polymerase I promoter (GO:0006360) | 2.91430259 |
| 168 | positive regulation of cell cycle arrest (GO:0071158) | 2.90364713 |
| 169 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.87923028 |
| 170 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.85737195 |
| 171 | termination of RNA polymerase I transcription (GO:0006363) | 2.85467079 |
| 172 | IMP metabolic process (GO:0046040) | 2.84999345 |
| 173 | establishment of integrated proviral latency (GO:0075713) | 2.80262299 |
| 174 | protein localization to kinetochore (GO:0034501) | 2.78935431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.42162478 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.92690440 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.84994880 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.76533465 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.52506694 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.44967554 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.44071620 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.25220378 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.21364417 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.15625297 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.98631528 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.98430820 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.88625196 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.82814230 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.81253345 |
| 16 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.68868257 |
| 17 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.58824035 |
| 18 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.54881869 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.48457927 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.45005916 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.44253940 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43409469 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.42952287 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.28372438 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22135661 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.21913650 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19819770 |
| 28 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.17289691 |
| 29 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.13515552 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12035726 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11101990 |
| 32 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.09151284 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08833012 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.08623749 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.01103687 |
| 36 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93702134 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.91991315 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.87794188 |
| 39 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.84233749 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77349082 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76197832 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.75708881 |
| 43 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75307509 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67545430 |
| 45 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67483482 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.66251850 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.65453640 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64978148 |
| 49 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.64565159 |
| 50 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64219264 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63387501 |
| 52 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.61857839 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59688150 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57285444 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51302540 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49827276 |
| 57 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49310155 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48249915 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.48218197 |
| 60 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48087540 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46079152 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44782637 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42175159 |
| 64 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.41468483 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40115983 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38486106 |
| 67 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37796396 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35769564 |
| 69 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33772209 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33188675 |
| 71 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31824121 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31375376 |
| 73 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29262481 |
| 74 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28477443 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26270701 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22977078 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22823027 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22054963 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22047620 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.20008526 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18363863 |
| 82 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18274459 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17938430 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16830615 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16716376 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15200715 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15173941 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15148110 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10550806 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09279611 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09047840 |
| 92 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08781772 |
| 93 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08759048 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08384786 |
| 95 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08164051 |
| 96 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07264011 |
| 97 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06672654 |
| 98 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06514751 |
| 99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06085532 |
| 100 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05815000 |
| 101 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05550644 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05413385 |
| 103 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.04533544 |
| 104 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03523413 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03404460 |
| 106 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.03206476 |
| 107 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03095278 |
| 108 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03048296 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02939060 |
| 110 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02435122 |
| 111 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02225805 |
| 112 | MYC_22102868_ChIP-Seq_BL_Human | 1.00300438 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99737437 |
| 114 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99723547 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98471722 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97159524 |
| 117 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95071922 |
| 118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94225850 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93365755 |
| 120 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93088690 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92927513 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91443361 |
| 123 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89404488 |
| 124 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87753930 |
| 125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86921740 |
| 126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85430576 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83901551 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83262889 |
| 129 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81313641 |
| 130 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.78988402 |
| 131 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.78816416 |
| 132 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77336354 |
| 133 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77091835 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74700813 |
| 135 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73274740 |
| 136 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.72727335 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72608308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.39620769 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.01299357 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.92355078 |
| 4 | MP0008057_abnormal_DNA_replication | 3.89770396 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.88281937 |
| 6 | MP0003077_abnormal_cell_cycle | 3.51396071 |
| 7 | MP0008058_abnormal_DNA_repair | 3.29577461 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.10923264 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.81744728 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.56910028 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.48030895 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.40469056 |
| 13 | MP0000678_abnormal_parathyroid_gland | 2.33859639 |
| 14 | MP0002249_abnormal_larynx_morphology | 2.30676599 |
| 15 | MP0008789_abnormal_olfactory_epithelium | 2.28950416 |
| 16 | MP0003718_maternal_effect | 2.20497074 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.14290138 |
| 18 | MP0003186_abnormal_redox_activity | 2.09570403 |
| 19 | MP0005394_taste/olfaction_phenotype | 2.09052819 |
| 20 | MP0005499_abnormal_olfactory_system | 2.09052819 |
| 21 | MP0003786_premature_aging | 2.08953162 |
| 22 | MP0000749_muscle_degeneration | 2.06105342 |
| 23 | MP0008877_abnormal_DNA_methylation | 1.97828330 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.96975907 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.96975907 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.89096613 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.87654651 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.87332809 |
| 29 | MP0005671_abnormal_response_to | 1.85999164 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.82701745 |
| 31 | MP0001661_extended_life_span | 1.80380174 |
| 32 | MP0000049_abnormal_middle_ear | 1.77091191 |
| 33 | MP0000490_abnormal_crypts_of | 1.73686397 |
| 34 | MP0001730_embryonic_growth_arrest | 1.71102570 |
| 35 | MP0000751_myopathy | 1.70569485 |
| 36 | MP0009278_abnormal_bone_marrow | 1.67127830 |
| 37 | MP0002398_abnormal_bone_marrow | 1.63418037 |
| 38 | MP0009785_altered_susceptibility_to | 1.63414601 |
| 39 | MP0004147_increased_porphyrin_level | 1.63135673 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.62338064 |
| 41 | MP0000350_abnormal_cell_proliferation | 1.62065838 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.59535051 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.54963433 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.54753435 |
| 45 | MP0002019_abnormal_tumor_incidence | 1.53265362 |
| 46 | MP0002822_catalepsy | 1.52021545 |
| 47 | MP0009379_abnormal_foot_pigmentation | 1.51328051 |
| 48 | MP0002722_abnormal_immune_system | 1.49133979 |
| 49 | MP0000685_abnormal_immune_system | 1.48282717 |
| 50 | MP0000681_abnormal_thyroid_gland | 1.45135699 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.43909536 |
| 52 | MP0008995_early_reproductive_senescence | 1.43298989 |
| 53 | MP0002736_abnormal_nociception_after | 1.43234305 |
| 54 | MP0002102_abnormal_ear_morphology | 1.41460265 |
| 55 | MP0005501_abnormal_skin_physiology | 1.40539472 |
| 56 | MP0000313_abnormal_cell_death | 1.40360141 |
| 57 | MP0005025_abnormal_response_to | 1.38275779 |
| 58 | MP0002429_abnormal_blood_cell | 1.35764556 |
| 59 | MP0005330_cardiomyopathy | 1.35351966 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.34486734 |
| 61 | MP0001800_abnormal_humoral_immune | 1.33932194 |
| 62 | MP0002132_abnormal_respiratory_system | 1.33605714 |
| 63 | MP0008260_abnormal_autophagy | 1.33089832 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.32543778 |
| 65 | MP0001853_heart_inflammation | 1.32319427 |
| 66 | MP0005670_abnormal_white_adipose | 1.32246536 |
| 67 | MP0000716_abnormal_immune_system | 1.32167120 |
| 68 | MP0002723_abnormal_immune_serum | 1.31599412 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 1.30740117 |
| 70 | MP0001819_abnormal_immune_cell | 1.30253565 |
| 71 | MP0001849_ear_inflammation | 1.29488326 |
| 72 | MP0005410_abnormal_fertilization | 1.26714294 |
| 73 | MP0000537_abnormal_urethra_morphology | 1.26192045 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.26106668 |
| 75 | MP0004858_abnormal_nervous_system | 1.25339822 |
| 76 | MP0001929_abnormal_gametogenesis | 1.21257702 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.20493164 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.20228361 |
| 79 | MP0001764_abnormal_homeostasis | 1.18402529 |
| 80 | MP0000358_abnormal_cell_content/ | 1.17771748 |
| 81 | MP0002210_abnormal_sex_determination | 1.15049577 |
| 82 | MP0002080_prenatal_lethality | 1.14885594 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.14333370 |
| 84 | MP0005174_abnormal_tail_pigmentation | 1.13773282 |
| 85 | MP0002163_abnormal_gland_morphology | 1.13144651 |
| 86 | MP0000858_altered_metastatic_potential | 1.12255305 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 1.08518083 |
| 88 | MP0002419_abnormal_innate_immunity | 1.06792546 |
| 89 | MP0002095_abnormal_skin_pigmentation | 1.05964563 |
| 90 | MP0003137_abnormal_impulse_conducting | 1.05456360 |
| 91 | MP0003436_decreased_susceptibility_to | 1.05398527 |
| 92 | MP0003136_yellow_coat_color | 1.05185711 |
| 93 | MP0009840_abnormal_foam_cell | 1.03516489 |
| 94 | MP0001145_abnormal_male_reproductive | 1.03188414 |
| 95 | MP0000003_abnormal_adipose_tissue | 1.01660085 |
| 96 | MP0002405_respiratory_system_inflammati | 1.01434179 |
| 97 | MP0001697_abnormal_embryo_size | 1.00055923 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.99032726 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.96040544 |
| 100 | MP0010307_abnormal_tumor_latency | 0.95546644 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.95274294 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.94783900 |
| 103 | MP0000759_abnormal_skeletal_muscle | 0.94162353 |
| 104 | MP0003123_paternal_imprinting | 0.89498101 |
| 105 | MP0001968_abnormal_touch/_nociception | 0.86797149 |
| 106 | MP0005387_immune_system_phenotype | 0.86405808 |
| 107 | MP0001790_abnormal_immune_system | 0.86405808 |
| 108 | MP0000653_abnormal_sex_gland | 0.86254331 |
| 109 | MP0002160_abnormal_reproductive_system | 0.83640485 |
| 110 | MP0003724_increased_susceptibility_to | 0.82727127 |
| 111 | MP0005083_abnormal_biliary_tract | 0.82402160 |
| 112 | MP0001672_abnormal_embryogenesis/_devel | 0.81572698 |
| 113 | MP0005380_embryogenesis_phenotype | 0.81572698 |
| 114 | MP0001529_abnormal_vocalization | 0.81280643 |
| 115 | MP0008469_abnormal_protein_level | 0.81036875 |
| 116 | MP0004133_heterotaxia | 0.80824193 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.80275757 |
| 118 | MP0003866_abnormal_defecation | 0.79618867 |
| 119 | MP0002234_abnormal_pharynx_morphology | 0.78701265 |
| 120 | MP0001542_abnormal_bone_strength | 0.78691947 |
| 121 | MP0001188_hyperpigmentation | 0.77903562 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.77265392 |
| 123 | MP0002269_muscular_atrophy | 0.75621871 |
| 124 | MP0001873_stomach_inflammation | 0.75439798 |
| 125 | MP0001346_abnormal_lacrimal_gland | 0.75284115 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.74970130 |
| 127 | MP0001905_abnormal_dopamine_level | 0.72988012 |
| 128 | MP0001919_abnormal_reproductive_system | 0.72615361 |
| 129 | MP0005266_abnormal_metabolism | 0.72239237 |
| 130 | MP0003984_embryonic_growth_retardation | 0.72135513 |
| 131 | MP0001881_abnormal_mammary_gland | 0.71906012 |
| 132 | MP0005058_abnormal_lysosome_morphology | 0.71839917 |
| 133 | MP0005384_cellular_phenotype | 0.70758046 |
| 134 | MP0000372_irregular_coat_pigmentation | 0.70254455 |
| 135 | MP0002932_abnormal_joint_morphology | 0.69699909 |
| 136 | MP0008873_increased_physiological_sensi | 0.68724605 |
| 137 | MP0002088_abnormal_embryonic_growth/wei | 0.67992249 |
| 138 | MP0005451_abnormal_body_composition | 0.67180152 |
| 139 | MP0008872_abnormal_physiological_respon | 0.67146749 |
| 140 | MP0003698_abnormal_male_reproductive | 0.67024615 |
| 141 | MP0000015_abnormal_ear_pigmentation | 0.66684759 |
| 142 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66575138 |
| 143 | MP0002970_abnormal_white_adipose | 0.66233126 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.65953433 |
| 145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65673958 |
| 146 | MP0003315_abnormal_perineum_morphology | 0.65521183 |
| 147 | MP0000747_muscle_weakness | 0.60434205 |
| 148 | MP0005319_abnormal_enzyme/_coenzyme | 0.60070192 |
| 149 | MP0005389_reproductive_system_phenotype | 0.59209448 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57489961 |
| 151 | MP0002085_abnormal_embryonic_tissue | 0.57220721 |
| 152 | MP0004233_abnormal_muscle_weight | 0.56879773 |
| 153 | MP0008770_decreased_survivor_rate | 0.56809598 |
| 154 | MP0005377_hearing/vestibular/ear_phenot | 0.56224950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.95596680 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.72790710 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.71563114 |
| 4 | Cerebral hypomyelination (HP:0006808) | 4.17643330 |
| 5 | Breast hypoplasia (HP:0003187) | 4.03055691 |
| 6 | Reticulocytopenia (HP:0001896) | 3.95907732 |
| 7 | Aplastic anemia (HP:0001915) | 3.84810194 |
| 8 | Oral leukoplakia (HP:0002745) | 3.64059979 |
| 9 | Testicular atrophy (HP:0000029) | 3.61140102 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.59670501 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.57147627 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.46352710 |
| 13 | Cerebral edema (HP:0002181) | 3.37127019 |
| 14 | Rough bone trabeculation (HP:0100670) | 3.32334758 |
| 15 | Degeneration of anterior horn cells (HP:0002398) | 3.26217619 |
| 16 | Abnormality of the anterior horn cell (HP:0006802) | 3.26217619 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.24147513 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.24147513 |
| 19 | Hepatic necrosis (HP:0002605) | 3.15568169 |
| 20 | Macrocytic anemia (HP:0001972) | 3.12986690 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.04710037 |
| 22 | Progressive microcephaly (HP:0000253) | 3.01125377 |
| 23 | Carpal bone hypoplasia (HP:0001498) | 2.97870654 |
| 24 | Mitochondrial inheritance (HP:0001427) | 2.97486046 |
| 25 | Broad distal phalanx of finger (HP:0009836) | 2.97302062 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.96937688 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.92336758 |
| 28 | Increased serum lactate (HP:0002151) | 2.91391692 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.88577114 |
| 30 | Premature graying of hair (HP:0002216) | 2.85435592 |
| 31 | Increased CSF lactate (HP:0002490) | 2.83699709 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.79758011 |
| 33 | Abnormality of glycolysis (HP:0004366) | 2.76309028 |
| 34 | Increased serum pyruvate (HP:0003542) | 2.76309028 |
| 35 | Pallor (HP:0000980) | 2.76150262 |
| 36 | Exertional dyspnea (HP:0002875) | 2.75710921 |
| 37 | Progressive muscle weakness (HP:0003323) | 2.73322675 |
| 38 | IgM deficiency (HP:0002850) | 2.72068627 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.69996967 |
| 40 | Opisthotonus (HP:0002179) | 2.69525718 |
| 41 | Thrombocytosis (HP:0001894) | 2.66902545 |
| 42 | Stridor (HP:0010307) | 2.65384397 |
| 43 | Pancytopenia (HP:0001876) | 2.63157898 |
| 44 | Lipid accumulation in hepatocytes (HP:0006561) | 2.62417278 |
| 45 | Cerebral palsy (HP:0100021) | 2.61103083 |
| 46 | CNS hypomyelination (HP:0003429) | 2.59137569 |
| 47 | Bone marrow hypocellularity (HP:0005528) | 2.53336226 |
| 48 | Chromsome breakage (HP:0040012) | 2.52496482 |
| 49 | Patellar aplasia (HP:0006443) | 2.49690626 |
| 50 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.48156960 |
| 51 | Myopathic facies (HP:0002058) | 2.47733382 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.46311221 |
| 53 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.45458433 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.45282670 |
| 55 | Abnormal protein glycosylation (HP:0012346) | 2.45282670 |
| 56 | Abnormal glycosylation (HP:0012345) | 2.45282670 |
| 57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.45282670 |
| 58 | Poor suck (HP:0002033) | 2.44667513 |
| 59 | Selective tooth agenesis (HP:0001592) | 2.42067604 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.41171708 |
| 61 | Abnormality of the preputium (HP:0100587) | 2.39879799 |
| 62 | Microretrognathia (HP:0000308) | 2.38821859 |
| 63 | Abnormal trabecular bone morphology (HP:0100671) | 2.38067559 |
| 64 | Multiple enchondromatosis (HP:0005701) | 2.36083320 |
| 65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.35795450 |
| 66 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.35736264 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.34262489 |
| 68 | Petechiae (HP:0000967) | 2.33659181 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.31903745 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31903745 |
| 71 | CNS demyelination (HP:0007305) | 2.28111446 |
| 72 | Abnormal spermatogenesis (HP:0008669) | 2.27843200 |
| 73 | Cellular immunodeficiency (HP:0005374) | 2.27666459 |
| 74 | Poor head control (HP:0002421) | 2.27560796 |
| 75 | Renal Fanconi syndrome (HP:0001994) | 2.26189371 |
| 76 | Irregular epiphyses (HP:0010582) | 2.25177752 |
| 77 | Microvesicular hepatic steatosis (HP:0001414) | 2.24550348 |
| 78 | Respiratory difficulties (HP:0002880) | 2.23691047 |
| 79 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23567972 |
| 80 | Diaphragmatic weakness (HP:0009113) | 2.23352917 |
| 81 | Postnatal microcephaly (HP:0005484) | 2.22962547 |
| 82 | Secondary amenorrhea (HP:0000869) | 2.20734985 |
| 83 | Megaloblastic anemia (HP:0001889) | 2.19027094 |
| 84 | Lactic acidosis (HP:0003128) | 2.18535333 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.18528947 |
| 86 | Agnosia (HP:0010524) | 2.18006391 |
| 87 | Abnormality of chromosome stability (HP:0003220) | 2.16265620 |
| 88 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.14954439 |
| 89 | Exercise-induced myalgia (HP:0003738) | 2.14909206 |
| 90 | Lymphoma (HP:0002665) | 2.14601859 |
| 91 | Lethargy (HP:0001254) | 2.13949738 |
| 92 | Meckel diverticulum (HP:0002245) | 2.12733934 |
| 93 | Premature ovarian failure (HP:0008209) | 2.12217863 |
| 94 | Truncus arteriosus (HP:0001660) | 2.11236050 |
| 95 | Sparse eyelashes (HP:0000653) | 2.10593187 |
| 96 | Brushfield spots (HP:0001088) | 2.10491629 |
| 97 | 11 pairs of ribs (HP:0000878) | 2.09113749 |
| 98 | IgG deficiency (HP:0004315) | 2.08882224 |
| 99 | Myelodysplasia (HP:0002863) | 2.08542344 |
| 100 | Absent thumb (HP:0009777) | 2.07793352 |
| 101 | Cholecystitis (HP:0001082) | 2.07627444 |
| 102 | Abnormal gallbladder physiology (HP:0012438) | 2.07627444 |
| 103 | Emotional lability (HP:0000712) | 2.07230027 |
| 104 | Abnormality of the ileum (HP:0001549) | 2.06845723 |
| 105 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06298868 |
| 106 | Colon cancer (HP:0003003) | 2.06075425 |
| 107 | Optic disc pallor (HP:0000543) | 2.05971612 |
| 108 | Acute encephalopathy (HP:0006846) | 2.04778392 |
| 109 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.03254205 |
| 110 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.01952603 |
| 111 | Abnormality of reticulocytes (HP:0004312) | 2.01556209 |
| 112 | Retinal dysplasia (HP:0007973) | 2.01437322 |
| 113 | Type 2 muscle fiber atrophy (HP:0003554) | 1.98896205 |
| 114 | Hypertensive crisis (HP:0100735) | 1.98712781 |
| 115 | Hyperthyroidism (HP:0000836) | 1.96673859 |
| 116 | Muscle fiber atrophy (HP:0100295) | 1.94601402 |
| 117 | Respiratory failure (HP:0002878) | 1.92461817 |
| 118 | Personality changes (HP:0000751) | 1.92030315 |
| 119 | Absent epiphyses (HP:0010577) | 1.90865909 |
| 120 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.90865909 |
| 121 | Horseshoe kidney (HP:0000085) | 1.90184701 |
| 122 | Increased muscle lipid content (HP:0009058) | 1.89783614 |
| 123 | Optic nerve coloboma (HP:0000588) | 1.89066464 |
| 124 | Duplicated collecting system (HP:0000081) | 1.88244106 |
| 125 | Trismus (HP:0000211) | 1.86962803 |
| 126 | Exercise intolerance (HP:0003546) | 1.86671940 |
| 127 | Abnormality of T cells (HP:0002843) | 1.85337658 |
| 128 | Hypokinesia (HP:0002375) | 1.84639662 |
| 129 | Exercise-induced muscle cramps (HP:0003710) | 1.82868040 |
| 130 | Leukodystrophy (HP:0002415) | 1.80594658 |
| 131 | Death in infancy (HP:0001522) | 1.78191620 |
| 132 | Muscle stiffness (HP:0003552) | 1.75271404 |
| 133 | Hypoplasia of the thymus (HP:0000778) | 1.74008306 |
| 134 | Squamous cell carcinoma (HP:0002860) | 1.73033197 |
| 135 | Abnormality of the umbilical cord (HP:0010881) | 1.71284743 |
| 136 | Self-mutilation (HP:0000742) | 1.71197323 |
| 137 | Gliosis (HP:0002171) | 1.70648789 |
| 138 | Reticulocytosis (HP:0001923) | 1.70351300 |
| 139 | Redundant skin (HP:0001582) | 1.67579838 |
| 140 | Severe muscular hypotonia (HP:0006829) | 1.66538128 |
| 141 | Unsteady gait (HP:0002317) | 1.65890159 |
| 142 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.63732532 |
| 143 | J-shaped sella turcica (HP:0002680) | 1.62467111 |
| 144 | Seborrheic dermatitis (HP:0001051) | 1.61893294 |
| 145 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.61380359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.38286141 |
| 2 | VRK2 | 4.32792852 |
| 3 | WEE1 | 4.17735105 |
| 4 | STK16 | 4.00917740 |
| 5 | EIF2AK1 | 3.62407449 |
| 6 | NME2 | 3.16299347 |
| 7 | TRIB3 | 2.78077823 |
| 8 | TESK2 | 2.70332191 |
| 9 | EIF2AK3 | 2.53719300 |
| 10 | CDC7 | 2.51800722 |
| 11 | ACVR1B | 2.47968150 |
| 12 | SMG1 | 2.32782044 |
| 13 | PLK4 | 2.12546552 |
| 14 | VRK1 | 1.97004697 |
| 15 | TSSK6 | 1.95794474 |
| 16 | BRSK2 | 1.88737422 |
| 17 | PIM2 | 1.87546094 |
| 18 | SRPK1 | 1.87150502 |
| 19 | MAP4K1 | 1.81148893 |
| 20 | NEK2 | 1.58561626 |
| 21 | BCKDK | 1.53824598 |
| 22 | ERN1 | 1.52980746 |
| 23 | MAP4K2 | 1.42452259 |
| 24 | PLK1 | 1.41168350 |
| 25 | DYRK3 | 1.38309677 |
| 26 | CCNB1 | 1.37439942 |
| 27 | TTK | 1.35745994 |
| 28 | SIK1 | 1.35598816 |
| 29 | BLK | 1.33696926 |
| 30 | KDR | 1.33041326 |
| 31 | MUSK | 1.32563682 |
| 32 | TESK1 | 1.31401947 |
| 33 | IRAK3 | 1.31107990 |
| 34 | PASK | 1.26085832 |
| 35 | MKNK1 | 1.22095185 |
| 36 | NEK1 | 1.21058044 |
| 37 | BRAF | 1.20852518 |
| 38 | ARAF | 1.19171227 |
| 39 | BRSK1 | 1.18518121 |
| 40 | CDK7 | 1.16430555 |
| 41 | IRAK4 | 1.16242291 |
| 42 | ATR | 1.14379020 |
| 43 | AURKB | 1.13095239 |
| 44 | PRKD3 | 1.12766489 |
| 45 | TAOK2 | 1.09322892 |
| 46 | AURKA | 1.08315091 |
| 47 | MAP2K7 | 1.07655562 |
| 48 | MST4 | 1.06449840 |
| 49 | CDK19 | 1.06410344 |
| 50 | RPS6KA4 | 1.03126349 |
| 51 | CDK8 | 1.02204607 |
| 52 | CSNK1A1L | 1.01691981 |
| 53 | TLK1 | 1.00502354 |
| 54 | MAP2K2 | 0.97918926 |
| 55 | MAP3K11 | 0.97518126 |
| 56 | TXK | 0.97315540 |
| 57 | MAP3K8 | 0.95908306 |
| 58 | ZAP70 | 0.94658382 |
| 59 | NME1 | 0.94536579 |
| 60 | PDK4 | 0.94326585 |
| 61 | PDK3 | 0.94326585 |
| 62 | RPS6KB2 | 0.91854438 |
| 63 | PKN2 | 0.87055472 |
| 64 | EPHA2 | 0.86638376 |
| 65 | CSNK1G1 | 0.86251196 |
| 66 | SCYL2 | 0.85846524 |
| 67 | TEC | 0.85650654 |
| 68 | CHEK2 | 0.84582515 |
| 69 | KIT | 0.84233573 |
| 70 | TNK2 | 0.83381031 |
| 71 | PAK4 | 0.83126712 |
| 72 | CSNK1G2 | 0.80536066 |
| 73 | STK10 | 0.79726359 |
| 74 | PLK3 | 0.78008152 |
| 75 | TAOK1 | 0.77902155 |
| 76 | BTK | 0.75444108 |
| 77 | PBK | 0.74525579 |
| 78 | EIF2AK2 | 0.74407160 |
| 79 | ABL2 | 0.74241364 |
| 80 | PIM1 | 0.73457515 |
| 81 | PAK1 | 0.72828879 |
| 82 | CDK4 | 0.70657995 |
| 83 | DAPK3 | 0.70560044 |
| 84 | ZAK | 0.69102151 |
| 85 | TGFBR1 | 0.68900349 |
| 86 | CSNK2A1 | 0.67646177 |
| 87 | LIMK1 | 0.65479445 |
| 88 | NUAK1 | 0.65294201 |
| 89 | LRRK2 | 0.65224061 |
| 90 | MAP2K3 | 0.65069097 |
| 91 | MAP3K12 | 0.63959741 |
| 92 | EEF2K | 0.63566115 |
| 93 | CSF1R | 0.62317025 |
| 94 | CHEK1 | 0.62306258 |
| 95 | FLT3 | 0.60616026 |
| 96 | CSNK2A2 | 0.60251699 |
| 97 | MKNK2 | 0.58965032 |
| 98 | STK4 | 0.58144400 |
| 99 | TYK2 | 0.57797144 |
| 100 | SYK | 0.54962543 |
| 101 | IKBKB | 0.54158420 |
| 102 | ICK | 0.53611213 |
| 103 | RPS6KA5 | 0.52845430 |
| 104 | PRKD2 | 0.51464074 |
| 105 | MAPK11 | 0.51460708 |
| 106 | LYN | 0.50919387 |
| 107 | DYRK2 | 0.49748895 |
| 108 | MAPKAPK5 | 0.48197606 |
| 109 | AKT2 | 0.47258078 |
| 110 | MAP3K10 | 0.46809959 |
| 111 | DAPK1 | 0.45666356 |
| 112 | TAOK3 | 0.45345905 |
| 113 | TBK1 | 0.44523608 |
| 114 | CAMK2G | 0.44445304 |
| 115 | RAF1 | 0.43316662 |
| 116 | CLK1 | 0.41424313 |
| 117 | CDK11A | 0.40844931 |
| 118 | MAPKAPK3 | 0.40500636 |
| 119 | CDK14 | 0.36967586 |
| 120 | PRKCI | 0.36818744 |
| 121 | RPS6KL1 | 0.36614392 |
| 122 | RPS6KC1 | 0.36614392 |
| 123 | JAK3 | 0.36506822 |
| 124 | ILK | 0.36083123 |
| 125 | GRK6 | 0.35960089 |
| 126 | CDK2 | 0.35378534 |
| 127 | PDK2 | 0.34849000 |
| 128 | CSNK1G3 | 0.33616262 |
| 129 | CDK9 | 0.32554246 |
| 130 | RPS6KA1 | 0.32360331 |
| 131 | RPS6KA6 | 0.30550670 |
| 132 | LCK | 0.30366769 |
| 133 | CDK15 | 0.29891796 |
| 134 | PRPF4B | 0.29123070 |
| 135 | ATM | 0.29078916 |
| 136 | RPS6KA2 | 0.28748299 |
| 137 | CDK18 | 0.25431472 |
| 138 | LMTK2 | 0.25123689 |
| 139 | MAPKAPK2 | 0.21264199 |
| 140 | CDK1 | 0.21002688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.64964633 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.51562262 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.81044234 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.77330395 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.65557786 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.26023672 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.76948887 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.76110269 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.73043447 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.61177153 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.51207151 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.35776802 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.89316784 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.87626080 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 1.80650513 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.79303411 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.77000060 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71396493 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.66576244 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.65719772 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.60854179 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.60763809 |
| 23 | Purine metabolism_Homo sapiens_hsa00230 | 1.54662305 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.52932461 |
| 25 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40855593 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39549244 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39262736 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18583893 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17164313 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16075369 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14442785 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13014788 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12477164 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09482923 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09474960 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02157202 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99354262 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95359624 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.91552286 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90779064 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89745830 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88559240 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87668696 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83146817 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82008568 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79559776 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76964233 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75830067 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73553389 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72776906 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72541182 |
| 52 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72393795 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71307239 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.70759011 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67287928 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66820744 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64061114 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63401961 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62494242 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61675063 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60844143 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60255007 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59729098 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59310370 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58656365 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58248162 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56570512 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56189201 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.53849505 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.53783307 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53544292 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52998432 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52282445 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49650463 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47108213 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46680433 |
| 77 | Allograft rejection_Homo sapiens_hsa05330 | 0.45611023 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44655128 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44124791 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43590564 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43221713 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43054525 |
| 83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42142671 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.41203549 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40233740 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40036432 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.39946693 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39226758 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37636007 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.34473411 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34193761 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33983670 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33002619 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29574780 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29514490 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29256163 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28470131 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28256429 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27821906 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27278079 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.26575720 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24628460 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23172921 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22463337 |
| 105 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22275656 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22256475 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19518693 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19326798 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.18997215 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18914578 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18556594 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.18423370 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17091909 |
| 114 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.16929863 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.16584456 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16468706 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16445292 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.16333869 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16112054 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.16075039 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.16041572 |
| 122 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15616243 |
| 123 | Asthma_Homo sapiens_hsa05310 | 0.13633801 |
| 124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.12862985 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12070637 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11043599 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.10658863 |

